What is Alcami?
Alcami operates as a comprehensive contract development and manufacturing organization (CDMO) with a rich history spanning over four decades. Headquartered in North Carolina, the company offers extensive services to pharmaceutical and biotech firms, facilitating product advancement through all development phases. With a substantial footprint of 675,000 square feet across the United States, Alcami provides tailored and innovative solutions encompassing analytical development, sterile and oral solid manufacturing from clinical to commercial scales, packaging, microbiology, cGMP biostorage, environmental monitoring, and essential pharmaceutical support services. This broad spectrum of capabilities positions Alcami as a key partner for companies seeking to navigate the complexities of drug development and manufacturing.
How much funding has Alcami raised?
Alcami has raised a total of $31M across 1 funding round:
Unspecified
$31M
Unspecified (2021): $31M, investors not publicly disclosed
What's next for Alcami?
The substantial enterprise-level funding Alcami has attracted indicates a company poised for significant expansion and operational enhancement. This capital infusion is likely to fuel further investment in its extensive infrastructure, technological advancements, and potentially, strategic acquisitions to broaden its service offerings or geographic reach. As a mature player in the CDMO market, Alcami is well-positioned to capitalize on the increasing demand for outsourced development and manufacturing services, particularly for complex biologics and specialized dosage forms. Future strategic moves may involve enhancing its capacity for large-scale commercial manufacturing or deepening its expertise in niche therapeutic areas, solidifying its role as a critical enabler for its pharmaceutical and biotech clientele.
See full Alcami company page
